News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hively Brad
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/21/2023 |
4
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Granted 168,512 shares
@ $0
Granted 421,280 options to buy
@ $0.481, valued at
$202.6k
|
|
| 11/22/2022 |
4/A
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Sold 9,718 shares
@ $2.0278, valued at
$19.7k
|
|
| 11/21/2022 |
4
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Granted 103,469 shares
@ $0
Granted 525,188 options to buy
@ $1.87, valued at
$982.1k
|
|
| 11/17/2022 |
4
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Disposed/sold 9,718 shares
@ $2.0278, valued at
$19.7k
|
|
| 03/29/2022 |
4/A
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Granted 550,563 options to buy
@ $7.09, valued at
$3.9M
|
|
| 03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4/A
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Granted 141,380 shares
@ $0
Granted 212,070 shares
@ $0 |
|
| 11/16/2021 |
4
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Granted 141,380 shares
@ $0
Granted 212,070 shares
@ $0
Granted 993,460 options to buy
@ $0.85, valued at
$844.4k
Granted 823,971 options to buy
@ $0.85, valued at
$700.4k
|
|
| 11/16/2021 |
3
| Hively Brad (CEO) has filed a Form 3 on Oncology Institute, Inc. |
|
|